A mandatory federal registry might give FDA a better idea of which dietary supplement products are on the market, but will the agency have the resources to pursue bad actors?
There may be no better time than now to work with FDA and those at the agency who seem to want to work with industry to solve problems.
The Natural Products Association has submitted comments to FDA regarding the agency’s “Multi-Year Nutrition Innovation Strategy."
CDX is a repository wherein manufacturers can post and share additional product information directly with retailers.
Governor Jerry Brown of California has signed new hemp legislation into law, a move that greatly expands hemp farming in the state.
GRMA is about to conduct pilot audits, an important step toward becoming fully operational.
Probiotics have had a tough media run in recent months. Why now?
How ERP systems help companies mitigate risk and vet their recall preparedness.
In September, FDA released new draft guidance for probiotics indicating the agency will accept CFUs as a unit of measurement.
The Lentein brand of lentil protein has secured a Generally Recognized as Safe (GRAS) “no objections” letter from FDA, said the ingredient’s supplier, Parabel USA.
The Council for Responsible Nutrition says its Supplement Online Wellness Library (OWL) registry for dietary supplement products continues to evolve as the trade group sees opportunities for growth and improvement.
In a new study published in Clinical Toxicology, researchers analyzed higenamine-containing dietary supplements, noting that higenamine was present in these products at unpredictable quantities and with inaccurate label information.
Christen Davis of Lonza Consumer Health & Nutrition recently talked to Nutritional Outlook about how her company has implemented QbD, what it entails, and how this model can benefit all dietary supplement manufacturers.
The Standardized Information on Dietary Ingredients (SIDI) Work Group released an updated SIDI Protocol in September.
We asked the experts which ingredients have caught not just retailers’ and regulators’ eyes, but their own.
New regulations for Prop 65 warning labels went into effect on August 30, 2018.
An Australian company called Nuseed, a subsidiary of Nufarm Ltd., announced that USDA has deregulated the company’s proprietary omega-3 canola for cultivation in the U.S.
Supplier Natreon says PrimaVie is now the “first and only clinically backed organic shilajit available on the market.”
If FDA had a comprehensive, mandatory, industry-wide database of every single dietary supplement product on the market, would such information help regulators as well as industry better police the dietary supplement market? Also, how could FDA create such a registry?
AHPA says that NDI notifications compliant with regulatory requirements are up since this time last year.
Here’s what you need to know to protect your property.
The ingredient, marketed under the trade name PreticX in North America and promoted for gut health for the general population, is now considered safe to include in food and drinks such as bakery and dairy products, fruit jelly, chocolate, and soy drinks.
According to the lawsuit, Fruitful Longevity removed barcodes and expiration dates from DFH products and sold them on its Amazon.com storefront.
In July, attorney Scott Bass, who helped draft DSHEA, told Nutritional Outlook that mandatory product listing not only makes sense for industry but is also likely to happen in the near future.
On July 30, NPA announced it sent a letter to U.S. Trade Representative Robert E. Lighthizer stating that tariffs on Chinese goods “will cause disproportionate economic harm to U.S. interests and increase costs for small businesses and consumers.”
Innovation in the fiber market is alive and kicking again now that FDA has accepted citizen petitions to classify inulin and other non-digestible carbohydrates as legal dietary fibers.
On Tuesday, July 10, the Trump administration released a proposed second list of $200 billion worth of Chinese goods that will face up to a 10% tariff.
In the short time made available for public comments, a number of natural products groups have responded to USDA, citing issues with the proposal.
Nutritional Outlook sought the opinion of few industry stakeholders on whether, in their opinion, the Epidiolex drug approval further threatens the legal status of CBD supplements.
Nutritional Outlook spoke to Scott Steinford, executive director at large of the CoQ10 Association (Salt Lake City, UT), about how trade tensions could negatively affect U.S. and China consumers.
